Compare UE & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UE | WGS |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.7B |
| IPO Year | 2014 | 2020 |
| Metric | UE | WGS |
|---|---|---|
| Price | $19.58 | $67.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $23.50 | ★ $93.50 |
| AVG Volume (30 Days) | ★ 1.0M | 662.9K |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | ★ 4.40% | N/A |
| EPS Growth | 23.33 | ★ 62.37 |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $471,935,000.00 | $427,539,000.00 |
| Revenue This Year | N/A | $12.70 |
| Revenue Next Year | $1.33 | $24.31 |
| P/E Ratio | $106.06 | ★ N/A |
| Revenue Growth | 6.06 | ★ 39.97 |
| 52 Week Low | $18.46 | $32.21 |
| 52 Week High | $24.11 | $170.87 |
| Indicator | UE | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 46.88 | 40.47 |
| Support Level | $18.60 | $56.36 |
| Resistance Level | $22.01 | $73.04 |
| Average True Range (ATR) | 0.32 | 4.84 |
| MACD | 0.07 | 0.10 |
| Stochastic Oscillator | 76.30 | 26.15 |
Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.